Donald K. Lang
Lawyers
Advises on a broad range of corporate transactions, including IPOs and other equity offerings, straight and convertible debt financings, and mergers and acquisitions.
Don advises issuers and investment banks on a broad range of capital markets transactions, including initial public offerings, other equity offerings, and high-yield, investment-grade and convertible debt financings. He also advises clients on mergers and acquisitions, as well as other strategic corporate transactions and corporate governance matters for a range of early-stage to public companies. Don has experience across a variety of industries, including life sciences, healthcare, technology and energy.
Experience highlights
Recent representations
- Gyroscope Therapeutics $148.0 million Series C equity financing
- Playtika $600 million notes offering
- Playtika Holding $2 billion IPO
- Ingram Micro $7.2 billion acquisition by Platinum Equity
- AlphaFlow Series A equity financing
- GoodRx Holdings $1.3 billion IPO
- Personalis $125 million stock offering
- 1Life Healthcare $296 million secondary offering
- Amazon.com $10 billion notes offering
- Atara Biotherapeutics $175 million stock and pre-funded warrants offering
- 1Life Healthcare $275 million convertible senior notes offering
- Turning Point Therapeutics $325 million stock offering
- Inphi $506 million convertible senior notes offering
- NVIDIA $5 billion notes offering
- NIKE $6 billion notes offering
- 1Life Healthcare $282 million IPO
Education
J.D., Stanford Law School
B.A., History, DePaul University
Professional history
- Counsel, 2021-present
- Associate, 2014-2021